Walgreens Boots Alliance (NASDAQ:WBA – Get Free Report) issued an update on its FY25 earnings guidance on Friday morning. The company provided earnings per share (EPS) guidance of $1.40-$1.80 for the period, compared to the consensus estimate of $1.52. Walgreens Boots Alliance also updated its FY 2025 guidance to 1.400-1.800 EPS.
Analysts Set New Price Targets
WBA has been the topic of several research analyst reports. Jefferies Financial Group lowered their target price on shares of Walgreens Boots Alliance from $19.00 to $9.00 and set a “hold” rating on the stock in a research note on Wednesday, October 23rd. Truist Financial lowered their price objective on shares of Walgreens Boots Alliance from $13.00 to $10.00 and set a “hold” rating on the stock in a research report on Monday, October 7th. Evercore ISI boosted their target price on shares of Walgreens Boots Alliance from $7.50 to $10.00 and gave the company an “in-line” rating in a research note on Wednesday, October 16th. Barclays increased their price target on Walgreens Boots Alliance from $7.00 to $8.00 and gave the company an “underweight” rating in a report on Wednesday, October 16th. Finally, UBS Group lifted their price objective on Walgreens Boots Alliance from $9.00 to $10.00 and gave the stock a “neutral” rating in a report on Thursday, October 17th. Four investment analysts have rated the stock with a sell rating, nine have issued a hold rating and two have given a buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $12.58.
Get Our Latest Research Report on WBA
Walgreens Boots Alliance Stock Down 4.7 %
Walgreens Boots Alliance (NASDAQ:WBA – Get Free Report) last announced its quarterly earnings results on Friday, January 10th. The pharmacy operator reported $0.51 EPS for the quarter, beating analysts’ consensus estimates of $0.38 by $0.13. Walgreens Boots Alliance had a negative net margin of 5.85% and a positive return on equity of 14.23%. The firm had revenue of $39.50 billion during the quarter, compared to the consensus estimate of $37.40 billion. During the same quarter last year, the firm earned $0.66 EPS. The firm’s revenue for the quarter was up 7.6% compared to the same quarter last year. As a group, equities analysts predict that Walgreens Boots Alliance will post 1.53 EPS for the current fiscal year.
Walgreens Boots Alliance Announces Dividend
The company also recently declared a quarterly dividend, which was paid on Thursday, December 12th. Investors of record on Monday, November 18th were paid a dividend of $0.25 per share. The ex-dividend date was Monday, November 18th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 10.85%. Walgreens Boots Alliance’s dividend payout ratio is presently -9.99%.
About Walgreens Boots Alliance
Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.
See Also
- Five stocks we like better than Walgreens Boots Alliance
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- 3 EV Stocks Offering Unique Alternatives to Tesla
- What Are Dividend Champions? How to Invest in the Champions
- 3 Stocks Leveraging NVIDIA’s Strength for Profits
- Differences Between Momentum Investing and Long Term Investing
- Walgreens Stock Poised for a Rebound: Why Analysts Are Bullish
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.